a developer of new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTCVX | 36.20 | -0.10 | -0.28% |
Fidelity Advisor Convertible Secs M | |||
FSEKX | 13.25 | -0.15 | -1.12% |
Fidelity Advisor Sustainable U.S. Eq A | |||
AGYGX | 12.93 | -0.21 | -1.60% |
American Century Focused Global Gr Y | |||
FCCGX | 25.75 | -0.45 | -1.72% |
Fidelity Advisor Small Cap Growth C | |||
GSTIX | 13.76 | -0.31 | -2.20% |
Goldman Sachs Strategic Growth Instl |
A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with IMNM. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then IMNM could also see price increases.
Ticker / NAME | Correlation To ATXS | 1D Price Change % | ||
---|---|---|---|---|
ATXS | 100% | -7.14% | ||
IMNM - ATXS | 42% Loosely correlated | -11.09% | ||
INZY - ATXS | 42% Loosely correlated | -8.89% | ||
KALV - ATXS | 41% Loosely correlated | -3.16% | ||
SNDX - ATXS | 39% Loosely correlated | -5.72% | ||
KYMR - ATXS | 39% Loosely correlated | -8.67% | ||
More |